How can robot-assisted surgery provide value for money?
- PMID: 35047798
- PMCID: PMC8647572
- DOI: 10.1136/bmjsit-2020-000042
How can robot-assisted surgery provide value for money?
Abstract
Objectives: To develop an interactive tool that estimates what potential benefits are needed for the robot to provide value for money when compared with endoscopic or open surgical interventions.
Design: A generic online interactive tool was developed to analyze the (health) effects needed to compensate for the additional costs of using a surgical robotic system from a healthcare perspective. The application of the tool is illustrated with a hypothetical new surgical robotic platform. A synthesis of evidence from different sources was used combined with interviews with surgeons.
Setting: Flexible tool that can be adapted to flexible settings.
Participants: Any hospital patient group for which robotic, endoscopic or open surgical procedures may be considered as appropriate treatment alternatives (eg, urology, gynecology, and so on).
Intervention: Robotically assisted surgical interventions.
Comparator: Endoscopic or open surgical interventions.
Main outcome measures: Thresholds of how much (health) effect is needed for robot-assisted surgery to provide value for money and to become cost-effective.
Results: The utilization rate of the surgical robotic system and a reduction in complications appeared to be important aspects in determining the value for money. To become cost-effective, it was deemed important for new surgical robotic systems to have added clinical benefit and become less costly than the current system.
Conclusions: This paper and its assisting interactive tool can be used by clinicians, researchers, and policymakers to gain insight in the benefit needed to provide value for money when using a (new) surgical robotic system or, when the effects are known or can be estimated, to assess the value for money for a specific indication. For robotic surgery to provide most value for money, we recommend assessing for each indication whether the necessary effects seem achievable.
Keywords: health care costs; health technology; robotic surgical procedures.
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: MMR, JPCG and SP have received an unrestricted research grant from Siemens Healthineers for other but related research projects.
References
-
- Intuitive Surgical . Q2 Investor presentation, 2019. Available: https://isrg.gcs-web.com/static-files/0d3d24c1-849d-4495-8035-c17def42fd76 [Accessed 04 Jul 2018].
-
- Intuitive Surgical . Intuitive Announces first quarter earnings. intuitive surgical, 2019. Available: https://isrg.gcs-web.com/news-releases/news-release-details/intuitive-an... [Accessed 15 May 2019].
-
- Husereau D, Drummond M, Petrou S, et al. . Consolidated Health Economic Evaluation Reporting Standards (CHEERS)--explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force. Value Health 2013;16:231–50. 10.1016/j.jval.2013.02.002 - DOI - PubMed
-
- Zorginstituut Nederland . Costing manual: methodology of research costs and reference prices for economic evaluations in health care, 2016. Available: https://www.zorginstituutnederland.nl/publicaties/publicatie/2016/02/29/... [Accessed 25 Jul 2018].
LinkOut - more resources
Full Text Sources